# The Effect of BRIZO on Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hypertrophy (BPH)

> **NCT05227508** · NA · UNKNOWN · sponsor: **Se-cure Pharmaceuticals Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- BPH Without Urinary Obstruction and Other Lower Urinary Tract Symptoms (LUTS)

## Interventions

- **DIETARY_SUPPLEMENT:** BRIZO
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05227508
- **Lead sponsor:** Se-cure Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08
- **Primary completion:** 2024-01
- **Final completion:** 2024-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227508, "The Effect of BRIZO on Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hypertrophy (BPH)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05227508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*